Glioblastoma multiforme is one of the most aggressive brain tumors, which should be maximally resescted as much as possible to obtain further and better outcome. The standard adjuvant treatment at present is radiation therapy concomitant with temodal which approved in multiple phase III trials which demonstrated significant improvement in the outcome and survival of patients.